Cassava Investors Ink $31M Drug Suit Deal Alongside Appeal
By Bonnie Eslinger · June 22, 2026, 9:48 PM EDT
Cassava Sciences investors have asked a Texas federal judge to preliminarily approve a $31 million settlement that ends their claims the pharmaceutical company inflated its stock prices with misleading information about...
To view the full article, register now.